Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × HMPL-013 × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 31 Stomach Neoplasms 9 Colonic Neoplasms 3 Rectal Neoplasms 2 Carcinoma, Hepatocellular 2 Advanced Colorectal Carcinoma 2 Unresectable Metastatic Colorectal Cancer 1 Sarcoma 1 Patients With Advanced Metastatic Colorectal Cancer 1 Pancreatic Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 NSCLC 1 Metastatic Colorectal Adenocarcinoma 1 Metastasis Colorectal Cancer 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Gastric/Gastroesophageal Junction Adenocarcinoma 1 Gastric Cancer Adenocarcinoma Metastatic 1 Fruquintinib 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Adenocarcinoma 1 Advanced Solid Tumors 1 Advanced Gastric Cancer 1

Interventions

Cisplatin 80 Fluorouracil 66 Paclitaxel 62 Radiotherapy 56 Oxaliplatin 51 Irinotecan 35 Docetaxel 34 Leucovorin 32 Carboplatin 30 Capecitabine 26 Radiation 25 Surgical Procedures, Operative 20 pembrolizumab 17 Drug Therapy 15 Bevacizumab 15 Cetuximab 14 Nivolumab 12 tislelizumab 11 Chemoradiotherapy 11 Albumin-Bound Paclitaxel 10 camrelizumab 9 S 1 (combination) 9 Neoadjuvant Therapy 9 Esophagectomy 9 nimotuzumab 8 durvalumab 8 Trastuzumab 8 Radiotherapy, Intensity-Modulated 7 Gefitinib 7 nedaplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06646588 2024-10-17

SJZ-RMEEC01

Hebei Medical University Fourth Hospital

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡